InsiderSignal.AI

InsiderSignal.ai

ROIV - Roivant Sciences Ltd.

Insider Sale by Sukhatme Mayukh (Pres, CIO)

Stock Price (After Trade)
Stock Price (Before Trade)

Loading data...

Trade Summary

3 days ago, Sukhatme Mayukh, serving as Pres, CIO at Roivant Sciences Ltd. (ROIV), sold 1,330,868 shares at $21.72 per share, for a total transaction value of $28,902,500.00. Following this transaction, Sukhatme Mayukh now holds 18,836,547 shares of ROIV.

This sale represents a 7.00% decrease in Sukhatme Mayukh's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 29, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, December 31, 2025, 2 days after the trade was made.

Roivant Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Sukhatme Mayukh

Sukhatme Mayukh

Pres, CIO

Mayukh Sukhatme, M.D., is President and Chief Investment Officer at Roivant Sciences Ltd., a commercial-stage biotech company known for its hub-and-spoke business model that identifies, acquires, and develops new therapeutic programs through subsidiaries and collaborations[[1]](https://www.pharmavoice.com/news/chief-investment-officer-biopharma-roivant-mayukh-sukhatme/702727/)[[2]](https://fintool.com/app/research/companies/ROIV/people/mayukh-sukhatme)[[3]](https://www.marketscreener.com/insider/MAYUKH-SUKHATME-A0VMW1/)[[6]](https://www.roivant.com/about/leadership). Dr. Sukhatme has played a pivotal role in Roivant’s growth, overseeing the in-licensing and acquisition of programs that have led to all 10 of the company’s positive phase 3 studies, and orchestrating major deals such as the $3 billion sale of five subsidiaries to Sumitomo Dainippon Pharma[[1]](https://www.pharmavoice.com/news/chief-investment-officer-biopharma-roivant-mayukh-sukhatme/702727/). His background combines extensive experience in the New York investment world, where he spent 15 years analyzing and investing in development-stage biotech companies, with deep medical expertise as a physician[[1]](https://www.pharmavoice.com/news/chief-investment-officer-biopharma-roivant-mayukh-sukhatme/702727/)[[5]](https://theorg.com/org/roivant-sciences/org-chart/mayukh-sukhatme). Prior to joining Roivant in 2015, Dr. Sukhatme held leadership roles including Chief Business Officer and President of Roivant Pharma[[5]](https://theorg.com/org/roivant-sciences/org-chart/mayukh-sukhatme). He is recognized for his strategic vision in identifying high-impact therapeutic opportunities and building partnerships with pharmaceutical companies, biotechs, and academic institutions[[1]](https://www.pharmavoice.com/news/chief-investment-officer-biopharma-roivant-mayukh-sukhatme/702727/)[[6]](https://www.roivant.com/about/leadership). Dr. Sukhatme’s career highlights include key investments in the hepatitis C space and Alexion, and he continues to lead Roivant’s efforts in scouting and developing innovative therapies with broad patient impact[[1]](https://www.pharmavoice.com/news/chief-investment-officer-biopharma-roivant-mayukh-sukhatme/702727/).

View full insider profile →

Trade Price

$21.72

Quantity

1,330,868

Total Value

$28,902,500.00

Shares Owned

18,836,547

Trade Date

Monday, December 29, 2025

3 days ago

SEC Filing Date

Wednesday, December 31, 2025

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Roivant Sciences Ltd.

Company Overview

No company information available
View news mentioning ROIV

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/2715274

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime